Actavia Life Sciences, Inc.
RASP
Revenue
0.00
0.000.00%
6 Months ChangeAssets
48.61k
▲22.44k▲85.73%
3 Months ChangeLiabilities
2.05M
▲39.07k▲1.94%
3 Months ChangeFree Cash Flow
-2.63M
▲340.48k▲11.45%
18 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-20
Form 10-Q
ID: 0001213900-24-045020
2024-04-10
Form 8-K
ID: 0001213900-24-031860
2024-02-16
Form 10-Q
ID: 0001213900-24-014866
2023-10-26
Form 8-K
ID: 0001013762-23-006718
2023-08-14
Form 10-Q
ID: 0001213900-23-066494
2023-05-15
Form 10-Q
ID: 0001213900-23-039553
2023-03-02
Form 10-Q
ID: 0001213900-23-016696
2023-01-23
Form 8-K
ID: 0001213900-23-004391
2022-12-20
Form 8-K
ID: 0001213900-22-081282
2022-08-22
Form 10-Q
ID: 0001213900-22-050001